Why the study?
Does LVOT obstruction affect the extent of fibrosis and diastolic dysfunction in patients with hypertrophic cardiomyopathy?
Does LVOT obstruction affect the extent of fibrosis and diastolic dysfunction in patients with hypertrophic cardiomyopathy?
LVOT obstruction in hypertrophic cardiomyopathy may be associated with a greater extent of fibrosis and subsequent diastolic dysfunction.
Answers are grounded in this paper and cite their sources.
May support LVOT obstruction–fibrosis link in HCM; hypothesis-generating and should not yet change practice.
LVOT obstruction may play a role in the extent of fibrosis in HCM, possibly conditioning greater diastolic dysfunction.
No takes yet. Share an insight, caveat, or question.
Avegliano et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: